Thermographic Images as an Objective Method for Assessing the Efficacy of Steroidal Epidural Injections

Sponsor
Tel-Aviv Sourasky Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02725723
Collaborator
(none)
40
1

Study Details

Study Description

Brief Summary

Spinal stenosis is a prevalent diagnosis, which is handled in a heterogeneous manner by clinicians. Moreover, when using steroidal epidural injections, successful treatment is currently defined as the satisfaction of the patient from the treatments, a subjective and non-quantifiable indicator.

In this experiment, the investigators aim to evaluate thermographic images as an objective method for assessing the efficacy of steroidal epidural injections, the most common invasive treatment for pain associated with spinal stenosis

Condition or Disease Intervention/Treatment Phase
  • Device: Therm-AppTM TH, thermographic camera
  • Drug: epidural injection
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Thermographic Images as an Objective Method for Assessing the Efficacy of Steroidal Epidural Injections
Study Start Date :
Mar 1, 2016
Anticipated Primary Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Subject after epidural injection

Subjects are patients from the clinic who have been diagnosed with Lumbar spinal stenosis and determined eligible for receiving steroidal epidural injection for pain management

Device: Therm-AppTM TH, thermographic camera

Drug: epidural injection

Outcome Measures

Primary Outcome Measures

  1. Changes in Ts (Skin Temperature) will be determined at image taken by Therm-AppTM TH camera at the same region [Baseline and 30 min]

Secondary Outcome Measures

  1. Change in Pain Intensity by a 0 - 10 numerical rating scale (NRS), where 0 indicates "no pain" and 10 indicates "pain as bad as you can imagine". [Baseline, 1 month, 3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed a valid, IRB/EC-approved informed consent form

  • 18 years of age or older when written informed consent is obtained

  • Diagnosis of spinal stenosis by MRI or CT imaging

Exclusion Criteria:
  • Sensitivity to local anesthetics

  • Skin infection at the site of needle insertion

  • Had evidence of a peripheral neuropathy

  • Had clinical signs of peripheral vascular disease

  • Patient is pregnant

  • Clinical diagnosis of blood clotting disorder

  • Tumor or infection at spine as demonstrate at MRI Unbalanced Cardiac Insufficiency, hypertension & Diabetes cataract Stomach Ulcer

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Tel-Aviv Sourasky Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
michal roll, Chief Executive Officer, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT02725723
Other Study ID Numbers:
  • TASMC-16-SB-0650-15-CTIL
First Posted:
Apr 1, 2016
Last Update Posted:
Apr 1, 2016
Last Verified:
Mar 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 1, 2016